1 / 14

Myopathies

Myopathies. Madison Pilato. Myopathy. Case Congenital Myopathies Critical Illness Myopathy Inflammatory Myopathies References. Case. 68 yo M w/o significant medical history p/w slowly progressive muscle weakness for 5 years. First symptom R knee giving out on stairs

jnice
Download Presentation

Myopathies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Myopathies Madison Pilato

  2. Myopathy • Case • Congenital Myopathies • Critical Illness Myopathy • Inflammatory Myopathies • References

  3. Case 68 yo M w/o significant medical history p/w slowly progressive muscle weakness for 5 years. First symptom R knee giving out on stairs Today has difficulty rising from a chair and grasping with right hand Exam: Intact CN, sensation and DTRs RUE: 5/5 shoulder abduction, 5/5 elbow flexion and extension, 4/5 wrist flexion 5/5 wrist extension, 3-/5 finger flexion LUE: 4+/5 finger flexion, rest is 5/5 RLE: 4+/5 knee extension, rest 5/5 LLE: 4+/5 hip flexion, 3+/5 knee extension, 4+/5 dorsiflexion Case from Continuum, “Pattern Recognition Approach to Myopathy” Volume 12, Issue 3, p13-32

  4. Congenital Myopathies

  5. https://adc.bmj.com/content/88/12/1051 Core MyopathyCentral core disease • Clinical spectrum: apparent normalcy to severe weakness • Typically: hypotonia in infancy, developmental delay in childhood • Proximal limbs, axial muscles w/musculoskeletal abnormalities (hip dislocation, kyphoscoliosis, joint contractures) • Autosomal dominant • RYR1 mutation – majority of cases, rare resp weakness, rare cardiomyopathy. Malignant hyperthermia • SEPN1 severe respiratory weakness, severe scoliosis • Pathology: • Fibers w/regions devoid of oxidative enzyme activity • Predominance of type 1 muscle fibers RYR1 Malignant hyperthermia

  6. https://www.sciencedirect.com/science/article/pii/S0960896613009942#f0005https://www.sciencedirect.com/science/article/pii/S0960896613009942#f0005 Nemaline (rod) myopathy “Nema”=thread • Variable presentation; genetically heterogeneous (AD, AR) • Infantile hypotonia: prominent facial and respiratory weakness (classic presentation), severe form with 20% mortality • Adult-onset: head-drop, dysphagia, respiratory insufficiency • Pattern of weakness: facial muscles, neck/trunk flexors, dorsiflexors, toe extensors • Earlier onset usually more severe. Less severe forms can stabilize or even improve • Pathology: • Rod shaped structures within muscle fibers • atrophic fibers without grouping • Trichrome stain: reddish purple thread-like inclusions within sarcoplasm • Type 1 fiber predominance • Ultrastuctural – intracytoplasmic rod-shaped structures

  7. Centronuclear MyopathyMyotubular Myopathy • Clinically and genetically heterogeneous • Muscle fibers with large central nuclei that resemble myotubes (early fetal muscle fibers) • Severe, more common form is X linked. Occurs in male infants, marked hypotonia and weakness, respiratory muscle weakness and failure. Facial weakness and impaired bulbar function. Female carriers can have limb girdle or facial weakness. 1/3 die from respiratory complications in infancy • Less common form is AD or AR. Mild weakness and hypotonia may be unrecognized. • Pathology: • One or more centrally placed nuclei with surrounding clear area • Persistent fetal characteristics of muscle

  8. Steroids Neuromuscular Blockade Severe systemic illness Critical Illness MyopathyAKA acute quadriplegic myopathy • Critically ill patient cannot be weaned off of ventilator, diffuse flaccid paralysis • 2/3 conditions usually required: corticosteroid therapy, neuromuscularblockade, severe systemic illness (e.g., sepsis) • ~25% of critically ill patients on MV longer than 1 week • Rapid onset, proximal weakness; may be asymmetric, may be muscle wasting • More common females • Resolves 3 weeks to one year; stop any offending agents • Pathology: • atrophy of muscle fibers (non-specific) • Electronic microscopic features are diagnostic/pathognomonic, selective loss of thick (myosin) filaments

  9. Inflammatory Myopathies

  10. http://n.neurology.org/content/66/1_suppl_1/S20.figures-only Inclusion body myositis • Most common primary muscle disease over age 50; 3:1 male predominance • Slow symptom progression; asymmetric • Early involvement of quadriceps and ankle dorsiflexors; frequent falls • Early involvement wrist and finger flexor muscles • ~50% swallowing difficulties; ~1/3 facial weakness • Muscle atrophy can be prominent • Can include peripheral polyneuropathy and sensory complaints • Poorly responsive to immunosuppressive tx, 50% WC bound after 10 years • Tx: supportive, exercise, supplement with creatine monohydrate • Pathology: • Intracytoplasmic vacuoles rimmed with granular material; inclusions react w/Abs associated with neurodegenerative diseases including beta-amyloid, tau, ubiquitin • Ultrastructual: diagnostic feature, inclusions w/in muscle cytoplasm, nuclei or both

  11. Dermatomyositis= small vessel vasculitis • Proximal muscle weakness, weeks to months • Characteristic rash: red rash over eyelids and extremities (heliotrope, shawl, Gottrons) • Humorally mediated microangiopathy/vasculitis with ischemic necrosis of muscle fibers • Most common inflammatory myopathy of childhood, seen in all ages • 3:2 female predominance • Frequency of cancer increased for 3 years after onset in adults • Tx: immunosuppressive • Pathology: • Inflammation of perimysialblood vessels • Lymphocytes plus plasma cells and eosinophils (mixed infiltrate) • Necrosis and phagocytosis in groups (microinfarcts) • Perifascicular atrophy = sublethal myofiber stress @ distal end of blood supply

  12. Polymyositis • Controversial; diagnosis of exclusion • Proximal muscle weakness over weeks to months with elevated CPK without skin changes of dermatomyositis. 2:1 female predominance • Oculobulbar rarely affected • May be associated with other autoimmune/collagen vascular diseases • Tx with immunosuppressive therapies (corticosteroids); 1/3 pts left with disability • Pathology: • Lymphocytic inflammation surrounding and invading otherwise healthy-appearing muscle fibers. • Rimmed vacuoles (IBM) and other types of inflammatory cells should be absent • CD-8 positive T cells, muscle fibers demonstrate upregulation MHC-I

  13. References • Continuum, “Pattern Recognition Approach to Myopathy” Volume 12, Issue 3, p13-32 • Prayson Neuropathology, 2nd Edition, Skeletal Muscle and Peripheral Nerve Disorders • Up to date: Congenital Myopathies • Up to date: Clinical manifestations of dermatomyositis and polymyositis in adults

More Related